New combo of two drugs teaches the immune system to fight cancer
[ad_1] The idea of causing the immune system to hunt cancer cells and kill them has been confirmed by two FDA-approved CAR-T treatments for lymphoma, Novartis' Kymriah and Gilead's Yescarta, which both involve the removal of T cells from patients and their engineering. to be able to recognize cancer. But what would happen if an … Read more